Crisaborole Effective for Long-Term Maintenance in Mild-to-Moderate Eczema
WEDNESDAY, June 28, 2023 (HealthDay News) — Crisaborole is effective as a long-term maintenance therapy for pediatric and adult patients with mild-to-moderate atopic dermatitis (AD), according to a study published online May 15 in the American Journa…
Learn MoreCrisaborole Effective for Long-Term Maintenance in Mild-to-Moderate Eczema
WEDNESDAY, June 28, 2023 (HealthDay News) — Crisaborole is effective as a long-term maintenance therapy for pediatric and adult patients with mild-to-moderate atopic dermatitis (AD), according to a study published online May 15 in the American Journa…
Learn MoreADA: Once-Weekly Icodec Superior for Reduction in HbA1c
WEDNESDAY, June 28, 2023 (HealthDay News) — For patients with insulin-naive type 2 diabetes, once-weekly icodec is superior for reduction in hemoglobin A1c (HbA1c), according to a study published online June 24 in the Journal of the American Medical …
Learn MoreNewborn Screening for Severe Combined Immunodeficiency Improves Survival
WEDNESDAY, June 28, 2023 (HealthDay News) — Newborn screening for severe combined immunodeficiency (SCID) facilitating early identification results in improved survival, according to a study published online June 20 in The Lancet.Monica S. Thakar, M….
Learn MoreInstrumental Activities of Daily Living Test Could ID Alzheimer Disease
WEDNESDAY, June 28, 2023 (HealthDay News) — There is an association between simulated real-life instrumental activities of daily living (IADL) and interactions of amyloid and early tau accumulation among cognitively normal older adults, according to …
Learn MoreWidening Gap ID’d in Housing Affordability for Resident Physicians
TUESDAY, June 27, 2023 (HealthDay News) — Resident physicians face a widening gap in housing affordability, with growth in rental prices outpacing that of resident earnings, according to a research letter published online June 27 in JAMA Network Open…
Learn MoreE-Cigarette Sales Up 46.6 Percent From January 2020 to December 2022
TUESDAY, June 27, 2023 (HealthDay News) — Electronic cigarette (e-cigarette) sales were 46.6 percent higher during December 2022 than during January 2020, according to research published in the June 23 issue of the U.S. Centers for Disease Control a…
Learn MoreFDA Approves Litfulo for Teens, Adults With Alopecia Areata
TUESDAY, June 27, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was…
Learn MoreADA: Once-Weekly Tirzepatide Leads to Weight Loss in Patients With Obesity, T2D
TUESDAY, June 27, 2023 (HealthDay News) — Once-weekly tirzepatide provides substantial and clinically meaningful reductions in body weight in adults with obesity and type 2 diabetes, according to a study published online June 26 in the The Lancet to …
Learn MoreADA: Once-Daily Semaglutide Superior for Reduction in Body Weight
TUESDAY, June 27, 2023 (HealthDay News) — Oral semaglutide 50 mg once daily leads to a superior and clinically meaningful reduction in body weight for adults with overweight or obesity without type 2 diabetes, according to a study published online Ju…
Learn More